ACADIA Pharmaceuticals to Announce Third Quarter 2014 Financial Results on November 10, 2014
ACADIA to Host Conference Call and Webcast on Monday, November 10,
2014, at 5:00 p.m. Eastern Time
SAN DIEGO—(BUSINESS WIRE)—Nov. 3, 2014—ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company
focused on the development and commercialization of innovative medicines
that address unmet medical needs in neurological and related central
nervous system disorders, today announced that it will report its
unaudited financial results for the third quarter ended September 30,
2014 on Monday, November 10, 2014, after the U.S. financial markets
close. ACADIA's management will host a conference call and webcast on
Monday, November 10, 2014, at 5:00 p.m. Eastern Time to discuss ACADIA’s
financial results and development programs.
The conference call may be accessed by dialing 866-318-8615 for
participants in the United States or Canada and 617-399-5134 for
international callers (reference passcode 86826740). A telephone replay
of the conference call may be accessed through November 24, 2014 by
dialing 888-286-8010 for callers in the United States or Canada and
617-801-6888 for international callers (reference passcode 62605343).
The conference call also will be webcast live on ACADIA’s website, www.acadia-pharm.com
under the investors section and will be archived there until November
24, 2014.
Source: ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc.
Steve Davis, Executive Vice
President,
Chief Financial Officer and Chief Business Officer
Lisa
Barthelemy, Director of Investor Relations
858-558-2871